Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.
Announcement Roche, a leading multinational healthcare giant drug investigation and efforts for early stage breast cancer has finally showed progress. Roche’s oral SERD reduced death risk by 3...
Announcement Zealand, at its Capital Markets Day in London, gave an overview of its robust strategy for its weight management legacy initiatives, which will be finalised in the near term, and the fiv...
Announcement Amylyx Pharmaceuticals, Inc., a leading company, has showcased the presentation of early tolerability and safety data from the combined of results from the running work characterizing b...
Announcement Freenome Holdings, Inc., a leading early cancer detection company establishing blood-related screening tests and Perceptive Capital Solutions Corp, a known special purpose acquisition co...
Announcement Eli Lilly, the leading Pharmaceutical company, has been working towards improving and developing the healthcare sector from the core for more than a decade. The company is working to en...
Announcement The increased concern across the global healthcare sector is seeking acquisition, a strong trading business, or a valuable partnership to improve the specific regional healthcare sector...
Announcement Defence Therapeutics Inc., a leading biotechnology company modernising an exclusive intracellular delivery platform that allows more effective, safe and potent radiotherapeutic and antib...
Announcement PreveCeutical Medical Inc. is excited to declare its authorisation, as the Australian Patent Office has awarded Australian Patent No. AU2020212659, headlined “A Cyclic Peptide&rdq...
Announcement The first-ever AI-familiar biotech groundbreaking large and small molecule therapeutics discovery, 1910, has proudly announced that its robust AI model, CANDID-CNS™, is now a part ...
Announcement The Massachusetts-based Crescent Biopharma has joined forces with China’s Sichuan Kelun-Biotech to establish and advance the combined antibody-drug conjugate and PD-1/VEGF bispeci...
Speak with a healthcare analyst about your research, consulting, or platform needs.